Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000410259 | SCV000485981 | likely pathogenic | Pendred syndrome | 2016-03-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001381391 | SCV001579768 | pathogenic | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser19Alafs*47) in the SLC26A4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC26A4 are known to be pathogenic (PMID: 16283880, 25394566, 26252218, 26445815). This variant is present in population databases (no rsID available, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with Pendred syndrome (PMID: 26969326). ClinVar contains an entry for this variant (Variation ID: 370620). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV000410259 | SCV002027628 | likely pathogenic | Pendred syndrome | 2021-09-05 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV000410259 | SCV002079958 | pathogenic | Pendred syndrome | 2020-06-05 | no assertion criteria provided | clinical testing |